MDWerks, Inc. (MDWK): Letter to Shareholders A Message About Our Reporting Status
MDWerks, Inc. (MDWK) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 Letter to Shareholders A Message About Our Reporting Status MDWerks, Inc. (OTC: MDWK) | November 16, 2026 Dear Fellow Shareholders, Today MDWerks, Inc. filed a Form 15 with the Securities and Exchange Commission to deregister our common stock and suspend our SEC repo
How this was made
The 30-second read
Why it matters
The key trade implication is reduced SEC filing cadence and format, which can change valuation models, widen bid-ask spreads, and increase uncertainty around financial updates.
Market read
For MDWK traders, the disclosure regime changes from SEC filings to OTC Alternative Reporting, with explicit warnings about liquidity and restricted-share resale.
What to watch
The letter says MDWK intends to remain quoted on OTC Markets Pink and continue publishing annual and quarterly information, which may partially offset the loss of SEC filings.
Background
The company’s 8-K Item 7.01 furnishes a shareholder letter explaining its decision to file Form 15 and deregister from SEC reporting.
Ticker impact
MDWerks filed a Form 15 to deregister its common stock and stop SEC reporting, shifting disclosures to OTC Markets’ alternative standard.
Likely downward pressure or higher volatility as investors price in reduced disclosure and potential liquidity risk.
The filing is a primary corporate reporting-status change, and the letter explicitly warns trading liquidity and restricted-share resale may be affected.
Market effects
Highlights ongoing cost-cutting and reporting-status risk for small OTC issuers, which can affect sentiment toward similar microcaps.
Limited, primarily impacts US OTC market participants trading MDWK.
Low, this is a company-specific US OTC reporting change.
Counterpoint
If OTC Alternative Reporting Standard disclosures remain timely and investors adapt, the impact could be muted versus fears of information blackout.
Key entities
- companyMDWerks, Inc.
OTC-listed issuer that filed Form 15 to deregister and suspend SEC reporting obligations.
- venueOTC Markets
Platform the company says it will use for alternative reporting disclosures.
- regulatory_filingSEC Form 15
Filing used to deregister securities and suspend SEC reporting obligations.


